Atlas Trials

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

Clinical trial NCT06135415 · COMPLETED

Trial details

NCT number
NCT06135415
Sponsor
Almirall, S.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Keratosis, Actinic
Start date
2023-12-21
Primary completion
2025-04-30
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.